Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01318421
What this trial is testing

ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 12
Not applicableEnded earlyNCT02266121
What this trial is testing

Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary-progressive Multiple SclerosisCognitive Deficits+1 more
University Hospital of Mont-Godinne 100
Not applicableLooking for participantsNCT07732907
What this trial is testing

Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia

Who this might be right for
Multiple SclerosisProgressive Multifocal Leukoencephalopathy
Bristol-Myers Squibb 15
Not applicableStudy completedNCT03499314
What this trial is testing

A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
NYU Langone Health 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765212
What this trial is testing

Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Eva M.M. Strijbis 75
Testing effectiveness (Phase 2)Study completedNCT02166021
What this trial is testing

Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
Dimitrios Karussis 48
Testing effectiveness (Phase 2)Study completedNCT01259388
What this trial is testing

A Pilot Study of Lithium in Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
VA Office of Research and Development 23
Not applicableUnknownNCT06485115
What this trial is testing

Telerehabilitation in Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Universita di Verona 78
Not applicableLooking for participantsNCT06374108
What this trial is testing

Resistance Training and Corticospinal Excitability in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Aarhus 54
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Not applicableStudy completedNCT05236777
What this trial is testing

TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants

Who this might be right for
Multiple Sclerosis
Biogen 675
Testing effectiveness (Phase 2)Study completedNCT02988401
What this trial is testing

Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
Johns Hopkins University 105
Not applicableStudy completedNCT00704834
What this trial is testing

Gene Expression Profiles in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University of California, Davis 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07020715
What this trial is testing

A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University Hospital, Antwerp 14
Not applicableUnknownNCT03787446
What this trial is testing

PET Study in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of British Columbia 9
Not applicableStudy completedNCT03455582
What this trial is testing

Cognition Evolution and MRI Markers in PPMS Patients on 2 Years

Who this might be right for
Multiple Sclerosis, Primary Progressive
University Hospital, Bordeaux 66
Testing effectiveness (Phase 2)Study completedNCT01448252
What this trial is testing

T Cell Vaccination in Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hadassah Medical Organization 30
Not applicableLooking for participantsNCT03174938
What this trial is testing

The Swedish BioFINDER 2 Study

Who this might be right for
DementiaAlzheimer DiseaseParkinson Disease+10 more
Skane University Hospital 2,950
Early research (Phase 1)Study completedNCT02601885
What this trial is testing

A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AbbVie 20
Not applicableAvailableNCT06802328
What this trial is testing

Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients

Who this might be right for
Non-Active Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD
Next Page